Results and long term follow-up for 1581 patients with metastatic breast carcinoma treated with standard dose doxorubicin-containing chemotherapy
- 1 January 1999
- Vol. 85 (1) , 104-111
- https://doi.org/10.1002/(sici)1097-0142(19990101)85:1<104::aid-cncr15>3.0.co;2-r
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Long-term follow-up of patients with complete remission following combination chemotherapy for metastatic breast cancer.Journal of Clinical Oncology, 1996
- A note on quantifying follow-up in studies of failure timeControlled Clinical Trials, 1996
- A Scottish national mortality study assessing cause of death, quality of and variation in management of patients with testicular non-seminomatous germ-cell tumoursBritish Journal of Cancer, 1995
- Factors predicting long-term survival for metastatic breast cancer patients treated with high-dose chemotherapy and bone marrow supportCancer, 1994
- A comparison of two doses of adriamycin in the primary chemotherapy of disseminated breast carcinomaBritish Journal of Cancer, 1987
- Evaluation of high-dose versus standard FAC chemotherapy for advanced breast cancer in protected environment units: a prospective randomized study.Journal of Clinical Oncology, 1987
- Combination chemotherapy of metastatic breast carcinoma with cyclophosphamide, adriamycin, and peptichemioCancer, 1984
- Multivariate analysis of prognostic factors in metastatic breast cancer.Journal of Clinical Oncology, 1983
- Management of breast cancer patients failing adjuvant chemotherapy with adriamycin-containing regimensCancer, 1981
- Assessment of response to therapy in advanced breast cancer.A project of the programme on clinical oncology of the International Union against Cancer, Geneva, SwitzerlandCancer, 1977